| Table 3: Use of pharmacodynamic tests in each study. |
| | Study | CHDR99112 | CHDR0102 | CHDR0105 | CHDR0614 | CHDR0407 | | compound | TPA023 | TPACMP2 | SL65.1498 | Alprazolam | Zolpidem | | comparator | Lorazepam | Lorazepam | Lorazepam | NA | NA |
| | SEM | Done | Done | Done | Done | Done | | Sway | Done | Done | Done | Done | Done | | VAS BL | Done | Done | Done | Done | Done | | Smooth | ND | ND | Done | Done | Done | | Track | ND | ND | ND | Done | Done |
|
|
ND: not done; NA: not applicable; SEM: saccadic eye movement; Smooth: smooth pursuit; Sway: body sway; VAS BL: VAS Bond and Lader; Track: adaptive tracking.
|